tert-Butyl 2-formylazepane-1-carboxylate

Catalog No.: 
ACKGCQ187
CAS No.: 
146337-41-9
Molecular Formula: 
C12H21NO3
Molecular Weight: 
227.30
tert-Butyl 2-formylazepane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$78.00In stockInquiry
50mg95%$132.00In stockInquiry
100mg95%$223.00In stockInquiry
250mg95%$378.00In stockInquiry
1g95%$1020.00In stockInquiry
5g95%$4079.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-formylazepane-1-carboxylate
IUPAC Nametert-butyl 2-formylazepane-1-carboxylate
MDL No.MFCD07776597
Molecular FormulaC12H21NO3
Molecular Weight227.30
SMILESO=C(N1C(C=O)CCCCC1)OC(C)(C)C
InChI KeyYYVXGCZFWGOISI-UHFFFAOYSA-N
Synonymtert-Butyl 2-forMylazepane-1-carboxylate;1-BOC-2-AZEPANECARBALDEHYDE;1H-Azepine-1-carboxylic acid, 2-formylhexahydro-, 1,1-dimethylethyl ester
CAS No.146337-41-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACKGCQ187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKUWA739 route compound structure diagram
    ACKUWA739889942-60-3In Stock
  2. Then
  3. ACKGCQ187 route product structure diagram
    ACKGCQ187146337-41-9In Stock
Inquiry

2. ACKGCQ187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKGCQ187 route product structure diagram
    ACKGCQ187146337-41-9In Stock
Inquiry

3. ACKGCQ187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKGCQ187 route product structure diagram
    ACKGCQ187146337-41-9In Stock
Inquiry

Comments (0)